Donald S. Karanewsky, Ph.D.
Scientific Advisor (formerly SVP and Chief Scientific Officer)
Dr. Karanewsky joined Senomyx in June 2007 as Senior Vice President, Discovery; was appointed Chief Scientific Officer in June 2010 and served in this role until his retirement in October 2015. Dr. Karanewsky has directed research teams and had senior management roles at a number of biotechnology institutions including Idun Pharmaceuticals, Ligand Pharmaceuticals and The Genomics Institute of the Novartis Research Foundation (GNF). In addition, he held principal positions at Glaxo Inc, Bristol-Myers Squibb, and the Squibb Institute for Medical Research. He received his Ph.D. and Master’s degrees in Chemistry from Harvard University and was granted a B.S. in Chemistry, magna cum laude, from Stevens Institute of Technology in New Jersey. Dr. Karanewsky is an inventor on over 100 issued US patents and has authored over 80 scientific publications.